Finder makes money from featured partners, but editorial opinions are our own.

Best performing stocks on the ASX in 2024 (Updated weekly)

We've collected the top performing stocks in Australia so that you don't need to.

Looking for the best performing stocks in Australia? We update this guide every Monday with the 10 top performing stocks on the Australian Securities Exchange (ASX) over the past week.

We also display updated performance data from the last 12 months and 5-year period.

How did we get this list?

We scan the performance data of all ASX-listed stocks to find the 10 best performing each week.

To exclude some of the more volatile penny stocks, only stocks with market capitalisations of more than $500 million are included.

Before you dive in, it's important to be aware that past performance is no guarantee of future success. A great performing stock might decline in the future. So you should always do your research and look at your own individual needs and investment strategy to decide what stock is right for you.

Best performing stocks on the ASX

Stock list last update April 22, 2024.


Paladin Energy Ltd (PDN.AU)

Paladin Energy Ltd develops, explores for, owns, and operates uranium mines in Australia, Canada, and Africa. The company operates through Exploration, Namibia, and Australia segments.
  • Market cap: A$4.567 billion
  • YTD performance: 5066.67%
  • 1-year performance: 2305.18%
  • 5-year performance: 36610.53%
  • P/E ratio: 54.6429
  • Headquarters: Australia

DroneShield (DRO.AU)

DroneShield Limited engages in the development, commercialization, and sale of hardware and software technology for drone detection and security in Australia and the United States. It offers DroneGun Tactical, a portable rifle shape drone disruptor, causing the drone to safely land, or fly back to the starting point; DroneGun Mk4, a rugged handheld counter-unmanned aircraft system (UAS) effector; DroneGun Mk3, a pistol shaped compact drone disruptor; RfPatrol Mk2, a wearable AI-enabled multi-mission detection tool; DroneSentry-X, a cross-vehicle compatible automated 360° detect and defeat device; and DroneSentry-X Mk2 is a software-defined detection and adaptive disruption system.
  • Market cap: A$690.485 million
  • YTD performance: 388.89%
  • 1-year performance: 309.31%
  • 5-year performance: 911.5%
  • P/E ratio: 56
  • Headquarters: Australia

Westgold Resources (WGX.AU)

Westgold Resources Limited engages in the exploration, operation, development, mining, and treatment of gold assets primarily in Western Australia. The company's assets include Bryah Operations, Murchison Operations, Meekatharra Gold Operations, and Cue Gold Operations that comprise various mining titles covering 1,300 square kilometers in the Murchison region.
  • Market cap: A$1.078 billion
  • YTD performance: -15.09%
  • 1-year performance: 67.92%
  • 5-year performance: 210.35%
  • P/E ratio: 16.25
  • Headquarters: Australia

Fineos Corporation Holdings Plc (FCL.AU)

FINEOS Corporation Holdings plc, together with its subsidiaries, engages in the development and sale of enterprise claims and policy management software for employee benefits and life, accident, and health insurance industries worldwide. The company offers FINEOS Platform, a Software-as-a-Service core insurance platform.
  • Market cap: A$592.061 million
  • YTD performance: -51.66%
  • 1-year performance: 12.26%
  • 5-year performance: 58.19%
  • P/E ratio: N/A
  • Headquarters: Australia

Telix Pharmaceuticals (TLX.AU)

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and related medical devices for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. Its lead products include TLX591-CDx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX250-CDx that is in Phase III clinical trials for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for the diagnosis and treatment of glioblastoma (brain cancer); TLX66-CDx to treat bone marrow conditioning and rare diseases; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; TLX250, which is in Phase II clinical trials for the diagnosis and treatment of kidney cancer; TLX591, which is in Phase III clinical trials for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX101 that is in Phase II clinical trials for the treatment of glioblastoma (brain cancer); TLX66, which is in Phase II clinical trials for the treatment of bone marrow conditioning and rare diseases; and TLX300 that is in Phase I clinical trial for the treatment and diagnosis of soft tissue sarcoma.
  • Market cap: A$4.595 billion
  • YTD performance: 280.11%
  • 1-year performance: 73.9%
  • 5-year performance: 1785.72%
  • P/E ratio: 695.25
  • Headquarters: Australia

Alpha HPA Ltd (A4N.AU)

Alpha HPA Limited operates as a specialty metals and technology company. It primarily explores for high purity alumina (HPA) deposits.
  • Market cap: A$1.018 billion
  • YTD performance: 249.21%
  • 1-year performance: 69.24%
  • 5-year performance: 1122.23%
  • P/E ratio: N/A
  • Headquarters: Australia

Regis Resources Ltd (RRL.AU)

Regis Resources Limited, together with its subsidiaries, engages in the exploration, evaluation, and development of gold projects in Australia. It owns 100% interests in the Duketon gold project located in the North Eastern Goldfields of Western Australia; and the McPhillamys gold project situated in the Central Western region of New South Wales, as well as holds 30% interest in Tropicana Gold Project.
  • Market cap: A$1.67 billion
  • YTD performance: -43.5%
  • 1-year performance: 46.9%
  • 5-year performance: 58.96%
  • P/E ratio: N/A
  • Headquarters: Australia

AGL Energy Ltd (AGL.AU)

AGL Energy Limited supplies energy and other essential services to residential, small and large businesses, and wholesale customers in Australia. It operates through three segments: Customer Markets, Integrated Energy, and Investments.
  • Market cap: A$6.183 billion
  • YTD performance: -21.74%
  • 1-year performance: 19.02%
  • 5-year performance: 83.76%
  • P/E ratio: 16.1228
  • Headquarters: Australia

Raptor Resources Limited (RPL.AU)

Regal Partners Limited is a privately owned hedge fund sponsor. The firm invests in the public equity and hedging markets across the globe with a focus on Australia.
  • Market cap: A$746.304 million
  • 1-year performance: 58.89%
  • 5-year performance: 58.89%
  • P/E ratio: 290
  • Headquarters: Australia

Bank Of Queensland (BOQ.AU)

Bank of Queensland Limited, together with its subsidiaries, provides various financial services in Australia and New Zealand. The company operates in Retail Banking, BOQ Business, and Other segments.
  • Market cap: A$3.99 billion
  • YTD performance: -19.84%
  • 1-year performance: 21.97%
  • 5-year performance: 40.49%
  • P/E ratio: 15.641
  • Headquarters: Australia

You can buy these best performing shares from a platform below

Name Product Price per trade Inactivity fee Asset class International
eToro
Finder AwardExclusive
eToro
$0
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
Yes
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
CFD service. Capital at risk.
Join the world's biggest social trading network when you trade stocks, commodities and currencies from the one account.
CMC Invest
Finder Award
CMC Invest
$0
$0
ASX shares, Global shares, Options trading, US shares, ETFs
Yes
$0 brokerage on US, UK, Canadian and Japanese markets (FX spreads apply).
Trade over 45,000 shares and ETFs from Australia and 15 major global markets. Plus, buy Aussie shares or ETFs for $0 brokerage up to $1,000 (First buy order of each security, each day - excludes margin loan settled trades).
Moomoo Share Trading
US$0.99
$0
ASX shares, Global shares, US shares, ETFs
Yes
Finder exclusive: Get an additional 30 days on top of the regular brokerage-free period for new accounts. T&Cs apply.
Trade shares on the ASX, the US markets and buy ETFs with Moomoo. Plus join a community over 20 million investors.
Spaceship US Investing
US$0
$0
US shares, ETFs
Yes
Dive into US markets with $0 brokerage, starting with just a $10 investment.
Unlock US stocks and ETFs with minimal entry barriers, offering straightforward, low-cost options for new and seasoned investors.
Tiger Brokers
US$2
$0
ASX shares, Global shares, US shares, ETFs
Yes
Finder exclusive: 10 no-brokerage US or ASX market trades in the first 180 days + 7% p.a. on uninvested cash with first deposit of any amount, plus US$30 TSLA + US$30 NVDA shares with deposits up to AU$2000. T&Cs apply.
Trade Australian, US and Asian stocks with no minimum deposit on Tiger Broker’s feature-packed platform.
Webull
US$0.25
$0
ASX shares, Global shares, Options trading, US shares, ETFs
Yes
Sign up & deposit $200 to get $100 of rewards value, or deposit $1,000 to get $200 worth. Up to $5,450 value available. T&Cs apply.
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.
Saxo Invested
US$1
$0
ASX shares, Global shares, Options trading, US shares, ETFs
Yes
Access 22,000+ stocks on 50+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
loading

Important: The standard brokerage fee displayed is the trade cost for new customers to purchase $1,000 of either Australian or US shares. Where a platform charges different fees for both US and Australian shares we show the lower of the two. Where both CHESS sponsored and custodian shares are offered, we display the cheapest option.

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades. Read the Product Disclosure Statement (PDS) and Target Market Determination (TMD) for the product on the provider's website.

More guides on Finder

Go to site